Form 4 for BCPC BALCHEM CORP
Accepted 2024-03-12 00:00:00 ET · period of report 2024-03-08 · accession 0001140361-24-012827 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-03-12 | 2024-03-08 | BCPC | Tignor Michael Brent | SVP, Chief HR Off | M - OptEx | $85.40 | +4,200 | 13.7K | +44% | +$358.7K |
| DM | 2024-03-12 | 2024-03-08 | BCPC | Tignor Michael Brent | SVP, Chief HR Off | S - Sale+OE | $157.52 | -5,339 | 10.4K | -34% | -$841.0K |
| D | 2024-03-12 | 2024-03-08 | BCPC | Tignor Michael Brent | SVP, Chief HR Off | M - OptEx | $0.00 | -4,200 | 4,200 | -50% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-03-08 | M | A | 4,200 | $85.40 | 13,707 | D | — | — | (F1) Exercise of fully vested non-qualified stock options. (F2) Includes acquisition of shares (company match) under the Balchem Corporation 401(k) plan. |
| 2 | Common | Common Stock | 2024-03-08 | S | D | 2,078 | $158.22 | 8,368 | D | — | — | (F4) This transaction was executed in multiple sales ranging from $158.0000 to $158.7850 per share, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or any security holder of the issuer full information regarding the number of shares and prices at which the transactions were affected regarding this footnote. |
| 3 | Common | Common Stock | 2024-03-08 | S | D | 3,261 | $157.07 | 10,446 | D | — | — | (F3) This transaction was executed in multiple sales ranging from $157.0000 to $157.1900 per share, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or any security holder of the issuer full information regarding the number of shares and prices at which the transactions were affected regarding this footnote. |
| 4 | Derivative | Stock Options (right to buy) | 2024-03-08 | M | D | 4,200 | $0.00 | 4,200 | D | $85.40 · — to 2027-02-21 | 4,200 Common Stock | (F5) Stock options that vested 20% on February 21, 2018, 40% on February 21, 2019, and 40% on February 21, 2020, and are exercisable. |